The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Rise in ...

Aerosolized antibiotics deliver effective local drug concentrations to the infection site and decrease the risk of systemic side effects associated with oral or intravenous antibiotics.

To ensure satisfactory patient outcomes, medications must reach the site of action and remain active once there. [1] To increase efficacy and minimize toxicity, aerosolized medications have become ...